For laboratory research only. Not for human or veterinary use.
Bondi SP
Retatrutide (20mg) research product
Metabolic Research

Retatrutide (20mg)

SKU PEP-024-20MGIn Stock
$229.99AUD

20mg Retatrutide (Reta peptide) lyophilised research vial. Triple GLP-1/GIP/glucagon receptor agonist for in-vitro laboratory research, with domestic Australian dispatch.

20mg

Pricing and availability are verified by the commerce service when this item is added to your cart.

Batch documentation

Documentation is matched to its applicable batch.

Australian dispatch

Shipping details are confirmed before checkout.

Product information.

Core catalogue and analytical references for this research product.

Visit the CoA library
Presentation
20mg
CAS number
2381089-83-2
Reported purity
99.753%
Catalogue ID
PEP-024-20MG

Research-use guidance.

Important boundaries for responsible laboratory handling.

Laboratory use only

This product is supplied only for in-vitro research. It is not for human or veterinary use.

Verify the applicable batch

Use the SKU and batch identifier on the product label to locate the relevant analytical document.

Follow supplied documentation

Use the labelled storage and handling information associated with the delivered product and batch.

Related products.

More products from metabolic research.

View category
Cagrilintide (10mg) research product

Metabolic Research

Cagrilintide

Research grade · 10mg

$199.99$229.99
View product
Cagrilintide (5mg) research product

Metabolic Research

Cagrilintide

Research grade · 5mg

$109.99$129.99
View product
Retatrutide (10mg) research product

Metabolic Research

Retatrutide

Research grade · 10mg

$144.99
View product